P2Y2 Receptor Functions in Cancer: A Perspective in the Context of Colorectal Cancer

被引:9
作者
Gendron, Fernand-Pierre [1 ]
Placet, Morgane [1 ]
Arguin, Guillaume [1 ]
机构
[1] Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ, Canada
来源
PROTEIN REVIEWS, VOL 19 | 2017年 / 1051卷
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
P2Y(2) receptor; Cancer; Colorectal cancer; Extracellular nucleotides; 2; P2RY2; GENE; PROMOTES CELL INVASION; PURINERGIC RECEPTORS; LUNG-CANCER; TGF-BETA; EXTRACELLULAR NUCLEOTIDES; MESENCHYMAL TRANSITION; SURGICAL-MANAGEMENT; EPITHELIAL-CELLS; CARCINOMA CELLS;
D O I
10.1007/5584_2017_90
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purinergic signaling has recently emerged as a network of signaling molecules, enzymes and receptors that coordinates the action and behavior of cancerous cells. Extracellular adenosine 50 triphosphate activates a plethora of P2 nucleotide receptors that can putatively modulate cancer cell proliferation, survival and dissemination. In this context, the G protein-coupled P2Y(2) receptor was identified as one of the entities coordinating the cellular and molecular events that characterize cancerous cells. In this chapter, we will look at the contribution of the P2Y(2) receptor in cancer outcomes and use this information to demonstrate that the P2Y(2) receptor represents a drug target of interest in the setting of colorectal cancer, for which the role and function of this receptor is poorly defined. More particularly, we will review how the P2Y(2) receptor modulates cancer cell proliferation and survival, while promoting cell dissemination and formation of metastases. Finally, we will investigate how the P2Y(2) receptor can contribute to the detrimental development of drug resistance that is often observed in cancerous cells.
引用
收藏
页码:91 / 106
页数:16
相关论文
共 104 条
[1]   Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients [J].
Agteresch, HJ ;
Burgers, SA ;
van der Gaast, A ;
Wilson, JHP ;
Dagnelie, PC .
ANTI-CANCER DRUGS, 2003, 14 (08) :639-644
[2]   Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases [J].
Andres, A. ;
Mentha, G. ;
Adam, R. ;
Gerstel, E. ;
Skipenko, O. G. ;
Barroso, E. ;
Lopez-Ben, S. ;
Hubert, C. ;
Majno, P. E. ;
Toso, C. .
BRITISH JOURNAL OF SURGERY, 2015, 102 (06) :691-699
[3]   Adenomatous polyposis coli (APC):: a multi-functional tumor suppressor gene [J].
Aoki, Koji ;
Taketo, Makoto M. .
JOURNAL OF CELL SCIENCE, 2007, 120 (19) :3327-3335
[4]   Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients [J].
Aquea, Gisela ;
Bresky, Gustavo ;
Lancellotti, Domingo ;
Madariaga, Juan Andres ;
Zaffiri, Vittorio ;
Urzua, Ulises ;
Haberle, Sergio ;
Bernal, Giuliano .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) :1931-1936
[5]   The P2Y2 nucleotide receptor interacts with αv integrins to activate Go and induce cell migration [J].
Bagchi, S ;
Liao, ZJ ;
Gonzalez, FA ;
Chorna, NE ;
Seye, CI ;
Weisman, GA ;
Erb, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) :39050-39057
[6]   Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].
Bakin, AV ;
Tomlinson, AK ;
Bhowmick, NA ;
Moses, HL ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810
[7]  
Bakin AV, 2002, J CELL SCI, V115, P3193
[8]   G Protein-Coupled Receptors in Cancer [J].
Bar-Shavit, Rachel ;
Maoz, Myriam ;
Kancharla, Arun ;
Nag, Jeetendra Kumar ;
Agranovich, Daniel ;
Grisaru-Granovsky, Sorina ;
Uziely, Beatrice .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
[9]   Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism [J].
Bhowmick, NA ;
Ghiassi, M ;
Bakin, A ;
Aakre, M ;
Lundquist, CA ;
Engel, ME ;
Arteaga, CL ;
Moses, HL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) :27-36
[10]   The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer [J].
Bird, RP ;
Good, CK .
TOXICOLOGY LETTERS, 2000, 112 :395-402